{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:01:31Z","timestamp":1791928891117,"version":"4.3.4"},"reference-count":44,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"12","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2026,10,1]]},"DOI":"10.1167\/iovs.67.12.1","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:31:08Z","timestamp":1790861468000},"page":"1","source":"Crossref","is-referenced-by-count":0,"title":["Establishment of Uveal Melanoma Patient-Derived Organoids Using an Air\u2013Liquid Interface System for Translational Research"],"prefix":"10.1167","volume":"67","author":[{"given":"Leticia","family":"Ussem","sequence":"first","affiliation":[{"name":"University of Bonn, University Hospital Bonn, Department of Ophthalmology, Bonn, Germany"},{"name":"Division of Ophthalmic Pathology, University Hospital Bonn, Bonn, Germany"},{"name":"Mildred Scheel School of Oncology Aachen Bonn Cologne D\u00fcsseldorf (MSSO ABCD), Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin U.","family":"Loeffler","sequence":"additional","affiliation":[{"name":"University of Bonn, University Hospital Bonn, Department of Ophthalmology, Bonn, Germany"},{"name":"Division of Ophthalmic Pathology, University Hospital Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Tischler","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital Bonn, Bonn, Germany"},{"name":"Centrum for Integrated Oncology Aachen Bonn Cologne D\u00fcsseldorf (CIO ABCD), Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieta","family":"Toma","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital Bonn, Bonn, Germany"},{"name":"Centrum for Integrated Oncology Aachen Bonn Cologne D\u00fcsseldorf (CIO ABCD), Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Pelusi","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank G.","family":"Holz","sequence":"additional","affiliation":[{"name":"University of Bonn, University Hospital Bonn, Department of Ophthalmology, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Gulbins","sequence":"additional","affiliation":[{"name":"University of Bonn, University Hospital Bonn, Department of Ophthalmology, Bonn, Germany"},{"name":"Division of Ophthalmic Pathology, University Hospital Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"S\u00fcsskind","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Hospital T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Noberini","sequence":"additional","affiliation":[{"name":"Department of Experimental Oncology, European Institute of Oncology (IEO) IRCCS, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Bonaldi","sequence":"additional","affiliation":[{"name":"Department of Experimental Oncology, European Institute of Oncology (IEO) IRCCS, Milan, Italy"},{"name":"Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina C.","family":"Herwig-Carl","sequence":"additional","affiliation":[{"name":"University of Bonn, University Hospital Bonn, Department of Ophthalmology, Bonn, Germany"},{"name":"Division of Ophthalmic Pathology, University Hospital Bonn, Bonn, Germany"},{"name":"Centrum for Integrated Oncology Aachen Bonn Cologne D\u00fcsseldorf (CIO ABCD), Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"issue":"8","key":"bib1","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.3390\/biomedicines12081758","article-title":"Uveal melanoma: comprehensive review of its pathophysiology, diagnosis, treatment, and future perspectives","volume":"12","author":"Kulbay","year":"2024","journal-title":"Biomedicines"},{"issue":"2","key":"bib2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41571-022-00714-1","article-title":"Advances in the clinical management of uveal melanoma","volume":"20","author":"Carvajal","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"bib3","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/CMR.0000000000000121","article-title":"GNAQ and GNA11 mutations in uveal melanoma","volume":"24","author":"Shoushtari","year":"2014","journal-title":"Melanoma Res"},{"issue":"13","key":"bib4","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.3390\/cancers14133066","article-title":"GNAQ and GNA11 genes: a comprehensive review on oncogenesis, prognosis and therapeutic opportunities in uveal melanoma","volume":"14","author":"Silva-Rodr\u00edguez","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"9010","key":"bib5","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0140-6736(96)90736-9","article-title":"Prognostic implications of monosomy 3 in uveal melanoma","volume":"347","author":"Prescher","year":"1996","journal-title":"Lancet"},{"issue":"7","key":"bib6","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1001\/jamaophthalmol.2016.0903","article-title":"Driver mutations in uveal melanoma associations with gene expression profile and patient outcomes","volume":"134","author":"Decatur","year":"2016","journal-title":"JAMA Ophthalmol"},{"issue":"12","key":"bib7","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1136\/bjophthalmol-2014-305047","article-title":"Prognostic parameters in uveal melanoma and their association with BAP1 expression","volume":"98","author":"van Essen","year":"2014","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"bib8","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/ng.2674","article-title":"Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3","volume":"45","author":"Martin","year":"2013","journal-title":"Nat Genet"},{"issue":"5","key":"bib9","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.ophtha.2016.01.023","article-title":"Uveal melanomas with SF3B1 mutations: a distinct subclass associated with late-onset metastases","volume":"123","author":"Yavuzyigitoglu","year":"2016","journal-title":"Ophthalmology"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"100800","DOI":"10.1016\/j.preteyeres.2019.100800","article-title":"Uveal melanoma: towards a molecular understanding","volume":"75","author":"Smit","year":"2020","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"bib11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1167\/iovs.65.2.27","article-title":"Mass spectrometry-based profiling of histone post-translational modifications in uveal melanoma tissues, human melanocytes, and uveal melanoma cell lines\u2014a pilot study","volume":"65","author":"Herwig-Carl","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.exer.2019.04.001","article-title":"Spatial intratumor heterogeneity in uveal melanoma: tumor cell subtypes with a presumed invasive potential exhibit a particular epigenetic staining reaction","volume":"182","author":"Herwig-Carl","year":"2019","journal-title":"Exp Eye Res"},{"issue":"2","key":"bib13","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ccell.2017.07.003","article-title":"Integrative analysis identifies four molecular and clinical subsets in uveal melanoma","volume":"32","author":"Robertson","year":"2017","journal-title":"Cancer Cell"},{"issue":"1","key":"bib14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41598-021-03964-8","article-title":"Genome-wide aberrant methylation in primary metastatic UM and their matched metastases","volume":"12","author":"Smit","year":"2022","journal-title":"Sci Rep"},{"issue":"9","key":"bib15","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.3390\/cancers13092043","article-title":"How to make immunotherapy an effective therapeutic choice for uveal melanoma","volume":"13","author":"Marseglia","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"5","key":"bib16","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1111\/febs.15707","article-title":"Mass spectrometry-based characterization of histones in clinical samples: applications, progress, and challenges","volume":"289","author":"Noberini","year":"2022","journal-title":"FEBS J"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41419-025-08295-4","article-title":"Identification of targetable epigenetic vulnerabilities for uveal melanoma","volume":"17","author":"Yenisehirli","year":"2025","journal-title":"Cell Death Dis"},{"issue":"7","key":"bib18","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.3390\/ijms23073660","article-title":"Histone deacetylase (HDAC) inhibitors: a promising weapon to tackle therapy resistance in melanoma","volume":"23","author":"Palamaris","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"13","key":"bib19","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1167\/iovs.65.13.60","article-title":"Novel uveal melanoma patient-derived organoid models recapitulate human disease to support translational research","volume":"65","author":"Dalvin","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"bib21","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.medj.2024.08.010","article-title":"Patient-derived organoids in precision cancer medicine","volume":"5","author":"Tong","year":"2024","journal-title":"Med"},{"issue":"7","key":"bib22","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.cell.2018.11.021","article-title":"Organoid modeling of the tumor immune microenvironment","volume":"175","author":"Neal","year":"2018","journal-title":"Cell"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.3389\/fonc.2020.01775","article-title":"Cultivation of clear cell renal cell carcinoma patient-derived organoids in an air-liquid interface system as a tool for studying individualized therapy","volume":"10","author":"Esser","year":"2020","journal-title":"Front Oncol"},{"issue":"1","key":"bib24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s13402-025-01158-2","article-title":"Optimized patient-derived lung cancer organoids recapitulating the immune landscape for precision therapy evaluation","volume":"49","author":"Xing","year":"2026","journal-title":"Cell Oncol"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"1736505","DOI":"10.3389\/fonc.2025.1736505","article-title":"Reconstituting the head and neck tumor microenvironment with air-liquid interface organoids","volume":"15","author":"Zheng","year":"2025","journal-title":"Front Oncol"},{"issue":"1","key":"bib26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/cptx.40","article-title":"Preparation of human primary colon tissue-derived organoid using air liquid interface culture","volume":"75","author":"Usui","year":"2018","journal-title":"Curr Protoc Toxicol"},{"issue":"1","key":"bib27","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3390\/cancers18010132","article-title":"Colorectal air-liquid interface organoids preserve tumour-immune architecture and reveal local Treg expansion after PD-1 blockade","volume":"18","author":"C\u00f3rdoba","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"1","key":"bib28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/pro.4218","article-title":"PANTHER: making genome-scale phylogenetics accessible to all","volume":"31","author":"Thomas","year":"2022","journal-title":"Protein Sci"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/978-1-60761-175-2","article-title":"PANTHER pathway: an ontology-based pathway database coupled with data analysis tools","volume":"563","author":"Mi","year":"2009","journal-title":"Methods Mol Biol"},{"issue":"3","key":"bib30","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41596-019-0128-8","article-title":"Protocol update for large-scale genome and gene function analysis with the PANTHER classification system (v.14.0)","volume":"14","author":"Mi","year":"2019","journal-title":"Nat Protoc"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ymeth.2019.10.001","article-title":"Enrichment of histones from patient samples for mass spectrometry-based analysis of post-translational modifications","volume":"184","author":"Noberini","year":"2020","journal-title":"Methods"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/978-1-0716-2863-8","article-title":"A super-SILAC approach for profiling histone posttranslational modifications","volume":"2603","author":"Noberini","year":"2023","journal-title":"Methods Mol Biol"},{"issue":"1","key":"bib33","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13148-021-01120-7","article-title":"Spatial epi-proteomics enabled by histone post-translational modification analysis from low-abundance clinical samples","volume":"13","author":"Noberini","year":"2021","journal-title":"Clin Epigenetics"},{"issue":"3","key":"bib34","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nbt.2839","article-title":"ProteomeXchange provides globally coordinated proteomics data submission and dissemination","volume":"32","author":"Vizca\u00edno","year":"2014","journal-title":"Nat Biotechnol"},{"issue":"8","key":"bib35","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1093\/nar\/gky224","article-title":"Extensive and systematic rewiring of histone post-translational modifications in cancer model systems","volume":"46","author":"Noberini","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"bib36","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.gendis.2022.11.022","article-title":"Ribonucleotide reductase M2 (RRM2): regulation, function and targeting strategy in human cancer","volume":"11","author":"Zuo","year":"2024","journal-title":"Genes Dis"},{"issue":"2","key":"bib37","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1755-148X.2012.00971.x","article-title":"Genetic and molecular characterization of uveal melanoma cell lines","volume":"25","author":"Griewank","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.21037\/aes-21-30","article-title":"Animal models of uveal melanoma","volume":"7","author":"Uner","year":"2022","journal-title":"Ann Eye Sci"},{"issue":"3","key":"bib39","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1074\/mcp.M115.054510","article-title":"Pathology tissue-quantitative mass spectrometry analysis to profile histone post-translational modification patterns in patient samples","volume":"15","author":"Noberini","year":"2016","journal-title":"Mol Cell Proteomics"},{"issue":"2","key":"bib40","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1158\/1541-7786.MCR-20-0434","article-title":"Dual screen for efficacy and toxicity identifies HDAC inhibitor with distinctive activity spectrum for BAP1-mutant uveal melanoma","volume":"19","author":"Kuznetsoff","year":"2021","journal-title":"Mol Cancer Res"},{"issue":"2","key":"bib41","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1158\/1078-0432.CCR-11-0946","article-title":"Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma","volume":"18","author":"Landreville","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"3","key":"bib42","doi-asserted-by":"publisher","first-page":"782","DOI":"10.3390\/cancers14030782","article-title":"Uveal melanoma cell line proliferation is inhibited by ricolinostat, a histone deacetylase inhibitor","volume":"14","author":"Sundaramurthi","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"12","key":"bib43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers12123690","article-title":"HDAC inhibition increases HLA class I expression in uveal melanoma","volume":"12","author":"Souri","year":"2020","journal-title":"Cancers (Basel)"},{"key":"bib20","first-page":"eadg6686","article-title":"A human mucosal melanoma organoid platform for modeling tumor heterogeneity and exploring immunotherapy combination options","volume-title":"Science Advances","author":"Sun","year":"2023"},{"key":"bib44","first-page":"7890","article-title":"Comprehensive bioinformatics analysis of ribonucleoside diphosphate reductase subunit M2(RRM2) gene correlates With prognosis and tumor immunotherapy in pan-cancer","volume-title":"Aging","author":"Wu","year":"2022"}],"container-title":["Investigative Ophthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.67.12.1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:32:13Z","timestamp":1791927133000},"score":1,"resource":{"primary":{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.67.12.1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.67.12.1","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,1]]}}}